Yichuan Yuan (Yunfei Yuan, Yun-Fei Yuan)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 27

Top Topics

Liver Metastases

Signaling Pathway

Radiofrequency Ablation

Top Venues

Alimentary pharmacology & therapeutics

Cancer medicine

Nature communications

Liver international : official journal of the International Association for the Study of the Liver

This page only lists publications with an associated author ORCID identifier.

Publications

Liang Qiao, Wei He, Guoying Wang, Huanwei Chen, Fuxi Huang, Bo Zhang, Yuxiong Qiu, Shaoru Liu, Zhenkun Huang, Yichuan Yuan, Jiliang Qiu, Yichuan Yuan, Bin-Kui Li
Regorafenib with immunotherapy versus regorafenib alone as second-line treatment for hepatocellular carcinoma: A multicenter real-world study. Cancer medicine 13 (9) (2024)
Yunxing Shi, Zongfeng Wu, Shaoru Liu, Dinglan Zuo, Yi Niu, Yuxiong Qiu, Liang Qiao, Wei He, Jiliang Qiu, Yichuan Yuan, Guocan Wang, Bin-Kui Li
Targeting PRMT3 impairs methylation and oligomerization of HSP60 to boost anti-tumor immunity by activating cGAS/STING signaling. Nature communications 15 (1) (2024)
Liang Qiao, Wei He, Guoying Wang, Huanwei Chen, Fuxi Huang, Bo Zhang, Yuxiong Qiu, Shaoru Liu, Zhenkun Huang, Yichuan Yuan, Jiliang Qiu, Yichuan Yuan, Bin-Kui Li
Regorafenib with immunotherapy versus regorafenib alone as second-line treatment for hepatocellular carcinoma: A multicenter real-world study. Cancer medicine 13 (9) (2024)
Liang Qiao, Wei He, Guoying Wang, Huanwei Chen, Fuxi Huang, Bo Zhang, Yuxiong Qiu, Shaoru Liu, Zhenkun Huang, Yichuan Yuan, Jiliang Qiu, Yichuan Yuan, Bin-Kui Li
Regorafenib with immunotherapy versus regorafenib alone as second-line treatment for hepatocellular carcinoma: A multicenter real-world study. Cancer medicine 13 (9) (2024)
Liang Qiao, Wei He, Guoying Wang, Huanwei Chen, Fuxi Huang, Bo Zhang, Yuxiong Qiu, Shaoru Liu, Zhenkun Huang, Yichuan Yuan, Jiliang Qiu, Yichuan Yuan, Bin-Kui Li
Regorafenib with immunotherapy versus regorafenib alone as second-line treatment for hepatocellular carcinoma: A multicenter real-world study. Cancer medicine 13 (9) (2024)
Yichuan Yuan, Wei He, Zhiwen Yang, Jiliang Qiu, Zhenkun Huang, Yunxing Shi, Zhu Lin, Yun Zheng, Minshan Chen, Wan Yee Lau, Binkui Li, Yunfei Yuan
TACE-HAIC combined with targeted therapy and immunotherapy versus TACE alone for hepatocellular carcinoma with portal vein tumor thrombus: a propensity score matching study. International journal of surgery (London, England) (2023)
Fangfang Bi, Yuxiong Qiu, Zongfeng Wu, Shaoru Liu, Dinglan Zuo, Zhenkun Huang, Binkui Li, Yichuan Yuan, Yi Niu, Ji-Liang Qiu
METTL9-SLC7A11 axis promotes hepatocellular carcinoma progression through ferroptosis inhibition. Cell death discovery 9 (1) (2023)
Yunxing Shi, Yi Niu, Yichuan Yuan, Kai Li, Chengrui Zhong, Zhiyu Qiu, Keren Li, Zhu Lin, Zhiwen Yang, Dinglan Zuo, Jiliang Qiu, Wei He, Chenwei Wang, Yadi Liao, Guocan Wang, Yichuan Yuan, Bin-Kui Li
PRMT3-mediated arginine methylation of IGF2BP1 promotes oxaliplatin resistance in liver cancer. Nature communications 14 (1) (2023)
Keren Li, Yi Niu, Kai Li, Chengrui Zhong, Zhiyu Qiu, Yichuan Yuan, Yunxing Shi, Zhu Lin, Zhenkun Huang, Dinglan Zuo, Yichuan Yuan, Bin-Kui Li
Dysregulation of PLOD2 Promotes Tumor Metastasis and Invasion in Hepatocellular Carcinoma. Journal of clinical and translational hepatology 11 (5) (2023)
Wei He, Bin-Kui Li, Yichuan Yuan
Editorial: is microwave ablation an alternative to liver resection for hepatocellular carcinoma? Alimentary pharmacology & therapeutics 57 (1) (2022)
Yuanping Zhang, Dinglan Zuo, Jiliang Qiu, Kai Li, Yi Niu, Yichuan Yuan, Yuxiong Qiu, Liang Qiao, Wei He, Chenwei Wang, Yichuan Yuan, Bin-Kui Li
NXN suppresses metastasis of hepatocellular carcinoma by promoting degradation of Snail through binding to DUB3. Cell death & disease 13 (8) (2022)
Wei He, Bin-Kui Li, Yichuan Yuan
Editorial: is microwave ablation an alternative to liver resection for hepatocellular carcinoma? Alimentary pharmacology & therapeutics 57 (1) (2022)
Kai Li, Yi Niu, Yichuan Yuan, Jiliang Qiu, Yunxing Shi, Chengrui Zhong, Zhiyu Qiu, Keren Li, Zhu Lin, Zhenkun Huang, Chao Zhang, Dinglan Zuo, Wei He, Yichuan Yuan, Bin-Kui Li
Insufficient ablation induces E3-ligase Nedd4 to promote hepatocellular carcinoma progression by tuning TGF-β signaling. Oncogene 41 (23) (2022)
Wei He, Bin-Kui Li, Yichuan Yuan
Editorial: is microwave ablation an alternative to liver resection for hepatocellular carcinoma? Alimentary pharmacology & therapeutics 57 (1) (2022)
Ling-Min Jiang, Yuan-Ping Zhang, Chen-Wei Wang, Wei-Dong Zhang, Wei He, Ji-Liang Qiu, Yi-Chuan Yuan, Bin-Kui Li, Yichuan Yuan, Ren-Chun Lai, Dan Dan Hu, Yun Zheng
More Liver Metastases Detected Intraoperatively Indicates Worse Prognosis for Colorectal Liver Metastases Patients after Resection Combined with Microwave Ablation. Journal of oncology 2022 (2022)
Xia Wang, Jin Wang, Yu-Man Tsui, Chaoran Shi, Ying Wang, Xin Zhang, Qian Yan, Miao Chen, Chen Jiang, Yichuan Yuan, Chun Ming Wong, Ming Liu, Zeng-Yu Feng, Hong-Lin Chen, Irene Oi Lin Ng, Lingxi Jiang, Xin-Yuan Guan
RALYL increases hepatocellular carcinoma stemness by sustaining the mRNA stability of TGF-β2. Nature communications 12 (1) (2021)
Chenwei Wang, Wei He, Binkui Li, Yichuan Yuan
Author response to Letter to the Editor: 'Are inflammation-based models feasible tools in predicting the outcome of patients with hepatocellular carcinoma?' Liver international : official journal of the International Association for the Study of the Liver 40 (6) (2020)
Xuming Tang, Tingting Cao, Yun Zhu, Liyi Zhang, Gina Jinna Chen, Tengfei Liu, Xiaoyan Ming, Shuo Fang, Yichuan Yuan, Lingxi Jiang, Jian-Dong Huang, Xin-Yuan Guan
PIM2 promotes hepatocellular carcinoma tumorigenesis and progression through activating NF-κB signaling pathway. Cell death & disease 11 (7) (2020)
Chenwei Wang, Yadi Liao, Jiliang Qiu, Yichuan Yuan, Yuanping Zhang, Kai Li, Ruhai Zou, Yongjin Wang, Dinglan Zuo, Wei He, Yun Zheng, Bin-Kui Li, Yichuan Yuan
Transcatheter arterial chemoembolization alone or combined with ablation for recurrent intermediate-stage hepatocellular carcinoma: a propensity score matching study. Journal of cancer research and clinical oncology 146 (10) (2020)
Wenwu Liu, Binkui Li, Yichuan Yuan
Letter: is microwave ablation superior to radiofrequency ablation for early stage hepatocellular carcinoma? Authors' reply. Alimentary pharmacology & therapeutics 48 (11-12) (2019)
Wenwu Liu, Ruhai Zou, Chenwei Wang, Jiliang Qiu, Jingxian Shen, Yadi Liao, Zhiwen Yang, Yuanping Zhang, Yongjin Wang, Yichuan Yuan, Kai Li, Dinglan Zuo, Wei He, Yun Zheng, Binkui Li, Yichuan Yuan
Microwave ablation versus resection for hepatocellular carcinoma within the Milan criteria: a propensity-score analysis. Therapeutic advances in medical oncology 11 (2019)
Wenwu Liu, Binkui Li, Yichuan Yuan
Letter: microwave vs radiofrequency ablation for hepatocellular carcinoma within the Milan criteria-Authors' reply. Alimentary pharmacology & therapeutics 48 (9) (2019)
Zhiwen Yang, Ruhai Zou, Yun Zheng, Jiliang Qiu, Jingxian Shen, Yadi Liao, Yuanping Zhang, Chenwei Wang, Yongjin Wang, Yichuan Yuan, Kai Li, Dinglan Zuo, Wei He, Wenwu Liu, Binkui Li, Yichuan Yuan
Lipiodol deposition in portal vein tumour thrombus predicts treatment outcome in HCC patients after transarterial chemoembolisation. European radiology 29 (11) (2019)
Chenwei Wang, Wei He, Yichuan Yuan, Yuanping Zhang, Kai Li, Ruhai Zou, Yadi Liao, Wenwu Liu, Zhiwen Yang, Dinglan Zuo, Jiliang Qiu, Yun Zheng, Binkui Li, Yichuan Yuan
Comparison of the prognostic value of inflammation-based scores in early recurrent hepatocellular carcinoma after hepatectomy. Liver international : official journal of the International Association for the Study of the Liver 40 (1) (2019)
Wei He, Yun Zheng, Ruhai Zou, Jingxian Shen, Junping Yang, Jiliang Qiu, Qiang Tao, Wenwu Liu, Zhiwen Yang, Yuanping Zhang, Binkui Li, Yichuan Yuan
Long- versus short-interval follow-up after resection of hepatocellular carcinoma: a retrospective cohort study. Cancer communications (London, England) 38 (1) (2018)
Wenwu Liu, Yun Zheng, Ruhai Zou, Jingxian Shen, Wei He, Zhiwen Yang, Yuanping Zhang, Binkui Li, Yichuan Yuan
Impact of follow-up interval on patients with hepatocellular carcinoma after curative ablation. BMC cancer 18 (1) (2018)
Wenwu Liu, Yun Zheng, Wei He, Ruhai Zou, Jiliang Qiu, Jingxian Shen, Zhiwen Yang, Yuanping Zhang, Chenwei Wang, Yongjin Wang, Dinglan Zuo, Binkui Li, Yichuan Yuan
Microwave vs radiofrequency ablation for hepatocellular carcinoma within the Milan criteria: a propensity score analysis. Alimentary pharmacology & therapeutics 48 (6) (2018)